|Widespread deregulation of microRNA expression in human prostate cancer|
M Ozen, CJ Creighton, M Ozdemir, M Ittmann
Oncogene 27 (12), 1788-1793, 2008
|LNCaP progression model of human prostate cancer: Androgen‐independence and osseous metastasis|
GN Thalmann, RA Sikes, TT Wu, A Degeorges, SM Chang, M Ozen, ...
The Prostate 44 (2), 91-103, 2000
|Interleukin-6 is an autocrine growth factor in human prostate cancer|
D Giri, M Ozen, M Ittmann
The American journal of pathology 159 (6), 2159-2165, 2001
|The role of fibroblast growth factors and their receptors in prostate cancer|
B Kwabi-Addo, M Ozen, M Ittmann
Endocrine-related cancer 11 (4), 709-724, 2004
|Establishment of two human prostate cancer cell lines derived from a single bone metastasis.|
NM Navone, M Olive, M Ozen, R Davis, P Troncoso, SM Tu, D Johnston, ...
Clinical cancer research: an official journal of the American Association …, 1997
|Genes that affect brain structure and function identified by rare variant analyses of Mendelian neurologic disease|
E Karaca, T Harel, D Pehlivan, SN Jhangiani, T Gambin, ZC Akdemir, ...
Neuron 88 (3), 499-513, 2015
|Human CLP1 mutations alter tRNA biogenesis, affecting both peripheral and central nervous system function|
E Karaca, S Weitzer, D Pehlivan, H Shiraishi, T Gogakos, T Hanada, ...
Cell 157 (3), 636-650, 2014
|Global gene expression analysis of reactive stroma in prostate cancer|
O Dakhova, M Ozen, CJ Creighton, R Li, G Ayala, D Rowley, M Ittmann
Clinical Cancer Research 15 (12), 3979-3989, 2009
|Fibroblast growth factor 2 promotes tumor progression in an autochthonous mouse model of prostate cancer|
N Polnaszek, B Kwabi-Addo, LE Peterson, M Ozen, NM Greenberg, ...
Cancer research 63 (18), 5754-5760, 2003
|Global transcriptional disturbances underlie Cornelia de Lange syndrome and related phenotypes|
B Yuan, D Pehlivan, E Karaca, N Patel, WL Charng, T Gambin, ...
The Journal of clinical investigation 125 (2), 636-651, 2015
|Hypoxic adipocytes pattern early heterotopic bone formation|
E Olmsted-Davis, FH Gannon, M Ozen, MM Ittmann, Z Gugala, JA Hipp, ...
The American journal of pathology 170 (2), 620-632, 2007
|Enhanced survival in perineural invasion of pancreatic cancer: an in vitro approach|
H Dai, R Li, T Wheeler, M Ozen, M Ittmann, M Anderson, Y Wang, ...
Human pathology 38 (2), 299-307, 2007
|Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway|
J Yan, CT Yu, M Ozen, M Ittmann, SY Tsai, MJ Tsai
Cancer research 66 (22), 11039-11046, 2006
|Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy|
E Pashaei, E Pashaei, M Ahmady, M Ozen, N Aydin
PloS one 12 (6), e0179543, 2017
|The properties of chopped basalt fibre reinforced self-compacting concrete|
Z Algin, M Ozen
Construction and Building Materials 186, 678-685, 2018
|Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal …|
KW Freeman, RD Gangula, BE Welm, M Ozen, BA Foster, JM Rosen, ...
Cancer research 63 (19), 6237-6243, 2003
|Role of fibroblast growth factor receptor signaling in prostate cancer cell survival|
M Ozen, D Giri, F Ropiquet, A Mansukhani, M Ittmann
Journal of the National Cancer Institute 93 (23), 1783-1790, 2001
|miR-1 and miR-133b are differentially expressed in patients with recurrent prostate cancer|
OF Karatas, E Guzel, I Suer, ID Ekici, T Caskurlu, CJ Creighton, M Ittmann, ...
PloS one 9 (6), e98675, 2014
|Overexpression of miR-145–5p inhibits proliferation of prostate cancer cells and reduces SOX2 expression|
M Ozen, OF Karatas, S Gulluoglu, OF Bayrak, S Sevli, E Guzel, ID Ekici, ...
Cancer investigation 33 (6), 251-258, 2015
|The function of microRNAs, small but potent molecules, in human prostate cancer|
S Sevli, A Uzumcu, M Solak, M Ittmann, M Ozen
Prostate cancer and prostatic diseases 13 (3), 208-217, 2010